Fitzpatrick A. Linda's Insider Trades & SAST Disclosures
Fitzpatrick A. Linda's most recent trade in Sutro Biopharma Inc was a trade of 13,538 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on May 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Fitzpatrick A. Linda.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.07 per share. | 01 May 2025 | 13,538 | 119,744 (0%) | 0% | 1.1 | 14,486 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 13,140 | 127,438 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 13,140 | 14,685 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 9,740 | 114,298 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 9,740 | 4,010 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 9,125 | 104,558 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 9,125 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 5,844 | 133,282 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 5,844 | 6,531 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 8,750 | 99,027 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 8,750 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.36 per share. | 05 Mar 2025 | 3,594 | 95,433 (0%) | 0% | 1.4 | 4,888 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 9,125 | 94,025 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 9,125 | 9,125 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.42 per share. | 04 Mar 2025 | 3,748 | 90,277 (0%) | 0% | 1.4 | 5,322 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 13,400 | 40,200 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 13,400 | 93,227 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. | 01 Mar 2025 | 8,327 | 84,900 (0%) | 0% | 1.6 | 13,240 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 6,875 | 79,827 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 6,875 | 13,750 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 37,100 | 37,100 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 28,500 | 28,500 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 16,500 | 16,500 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 8,750 | 76,060 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 8,750 | 8,750 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.54 per share. | 05 Mar 2024 | 3,108 | 72,952 (0%) | 0% | 4.5 | 14,110 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 9,125 | 71,049 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 9,125 | 18,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. | 04 Mar 2024 | 3,739 | 67,310 (0%) | 0% | 4.8 | 17,910 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 6,875 | 64,435 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 6,875 | 20,625 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 01 Mar 2024 | 2,511 | 61,924 (0%) | 0% | 4.9 | 12,429 | Common Stock |
| Sutro Biopharma Inc | A. Linda Fitzpatrick | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 8,250 | 60,940 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Fitzpatrick A. Linda | CHIEF PEOPLE & COMM. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 8,250 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | A. Fitzpatrick Linda | CHIEF PEOPLE & COMM. OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.99 per share. | 29 Jan 2024 | 3,380 | 57,560 (0%) | 0% | 5.0 | 16,866 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 27,500 | 27,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,125 | 27,375 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,125 | 50,335 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 8,750 | 17,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 8,750 | 59,085 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.79 per share. | 03 Mar 2023 | 6,395 | 52,690 (0%) | 0% | 5.8 | 37,027 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 8,250 | 44,574 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 8,250 | 8,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 27 Jan 2023 | 3,364 | 41,210 (0%) | 0% | 7.5 | 25,230 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 42,000 | 42,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 36,500 | 36,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 8,750 | 39,296 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 8,750 | 26,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. | 04 Mar 2022 | 2,972 | 36,324 (0%) | 0% | 8.2 | 24,281 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 8,250 | 33,926 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 8,250 | 16,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.39 per share. | 29 Jan 2022 | 3,380 | 30,546 (0%) | 0% | 10.4 | 35,118 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 7,576 | 28,295 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 7,576 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.23 per share. | 24 Sep 2021 | 2,619 | 25,676 (0%) | 0% | 19.2 | 50,363 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 35,000 | 35,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 8,250 | 24,750 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 8,250 | 23,866 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.15 per share. | 29 Jan 2021 | 3,147 | 20,719 (0%) | 0% | 22.1 | 69,706 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 1,652 | 0 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.36 per share. | 19 Jan 2021 | 1,652 | 15,616 (0%) | 0% | 4.4 | 7,203 | Common Stock |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 7,576 | 16,583 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 7,576 | 7,576 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Linda A. Fitzpatrick | Chief People & Comm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.30 per share. | 25 Sep 2020 | 2,619 | 13,964 (0%) | 0% | 10.3 | 26,976 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges